Plus Therapeutics | CYTX - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Baxter International USD 2.68B 3.36B 2026-06
Cerus USD 34.78M 2.98M 2024-12
Dr.Reddys Laboratories INR 77.75B 3.17B 2026-06
Haemonetics USD 145.34M 148.66M 2026-06
Northwest Biotherapeutics USD 11.39M 120.04M 2026-03
Plus Therapeutics USD 8.15M 1.04M 2026-03
Sanofi EUR 9.92B 607M 2026-06
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Sun Pharmaceuticals INR 117.43B 648.5M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06